Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Urologic Oncology Branch
Dr. Linehan pioneered the study of the genetic basis of kidney cancer. His team identified the genes for the common forms of kidney cancer and described the pathways of these kidney cancer genes. His recent studies targeting the metabolic basis of kidney cancer have resulted in the regression of metastatic cancer in patients with type 1 and type 2 papillary kidney cancer.
As Chief, Dr. Linehan oversees the Branch’s clinical/translational research program, which emphasizes new approaches to the therapies of genitourinary cancers, diagnostic and prognostic evaluation of solid GU tumors, and the development of innovative surgical and adjunctive approaches to the treatment of patients with primary and metastatic urologic cancer.
Areas of Expertise
1) VHL gene, 2) targeted therapy, 3) metabolic therapy, 4) clear cell kidney cancer, 5) papillary kidney cancer
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals